Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era

Clinics (Sao Paulo). 2020:75:e2033. doi: 10.6061/clinics/2020/e2033. Epub 2020 Jul 6.

Authors

Ali Alkan¹, Asaf Uncu², Irmak Taşkıran², Özgür Tanrıverdi¹

Affiliations

¹ Medical Oncology, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey.
² Internal Medicine, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey.

No abstract available

MeSH terms

Betacoronavirus
COVID-19
Coronavirus / isolation & purification*
Coronavirus Infections / drug therapy*
Coronavirus Infections / epidemiology
Granulocyte Colony-Stimulating Factor / pharmacology*
Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
Granulocytes
Humans
Immune System / drug effects*
Neoplasms / complications*
Neoplasms / drug therapy*
Neoplasms / immunology
Pandemics
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / epidemiology
SARS-CoV-2

Substances

Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor